LINDA BELLER: Open Payments
NPI 1437861366 · ORLAND PARK, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,922 in 114 payments from 22 companies in 2025. Trend: 2023 $904 · 2024 $1,768 · 2025 $1,922
Food & beverage: $1,922
| Company | Payments | Amount |
|---|---|---|
| Azurity Pharmaceuticals, Inc. | 28 | $216 |
| Lilly USA, LLC | 9 | $184 |
| Novo Nordisk Inc | 10 | $167 |
| ABBVIE INC. | 10 | $156 |
| Novartis Pharmaceuticals Corporation | 6 | $139 |
| Lundbeck LLC | 7 | $137 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $99 |
| Radius Health, Inc. | 4 | $92 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $91 |
| Corcept Therapeutics | 3 | $82 |
Products named: EDARBI, REXULTI, LEQVIO, MOUNJARO, JARDIANCE, TRINTELLIX, LINZESS, Tymlos.
Industry payments across IL — which companies pay providers there.
